Updated results from a trial with belzutifan for people with advanced kidney cancer
Kidney cancers frequently have mutations in the von Hippel-Lindau (VHL) gene, [...]
Kidney cancers frequently have mutations in the von Hippel-Lindau (VHL) gene, [...]
In this video interview, Dr Eric Jonasch from MD Anderson [...]
One of the major breakthroughs this year the hypoxia-inducible factor [...]
Von Hippel-Lindau (VHL) disease–associated renal cell carcinoma (RCC) has always [...]
Results from a phase II international trial led by researchers [...]
In this video interview, Dr Eric Jonasch from MD Anderson [...]
A recent review of the literature in European Urology summarises [...]
A research study, published online in eLife, has provided new [...]
The following video interviews with kidney cancer experts from the [...]
Von Hippel-Lindau (VHL) disease is caused by a change (mutation) [...]